Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Dolsten Mikael (CIK 1437590) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-09). Recent activity: Sell A (634 shares), Buy RCKT (22,862 shares), Sell A (1,600 shares), Sell APLS (14,312 shares), Sell APLS (14,312 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | AGILENT TECHNOLOGIES, INC. (A) | Director | Sell | 634 | $95,972 |
| 2026-07-06 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Director | Buy | 22,862 | $0 |
| 2026-06-02 | AGILENT TECHNOLOGIES, INC. (A) | Director | Sell | 1,600 | $216,672 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 14,312 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 14,312 | $0 |
| 2026-03-23 | AGILENT TECHNOLOGIES, INC. (A) | Director | Buy | 2,158 | $241,156 |
| 2026-03-03 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Buy | 14,312 | $0 |
| 2025-12-03 | AGILENT TECHNOLOGIES, INC. (A) | Director | Sell | 2,600 | $389,506 |
| 2025-07-18 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Director | Buy | 30,000 | $0 |
| 2025-04-24 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Director | Buy | 14,220 | $0 |
Source: SEC Form 4 filings · as of 2026-09-09